JY231 Injection
JY-CT-25-008
Unknown small_molecule active
Quick answer
JY231 Injection for B-cell Malignancies is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- B-cell Malignancies
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active